Hasil Pencarian - Revathi Ananthakrishnan
- Menampilkan 1 - 8 hasil dari 8
-
1
The Forces Behind Cell Movement oleh Revathi Ananthakrishnan, Allen Ehrlicher
Diterbitkan 2007-01-01
Artikel -
2
Pharmacological modeling and biostatistical analysis of a new drug oleh Revathi Ananthakrishnan, Philimon Gona
Diterbitkan 2010-04-01
Artikel -
3
2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy oleh Revathi Ananthakrishnan, Stephanie Green, Daniel Li, Michael LaValley
Diterbitkan 2019-12-01
Artikel -
4
Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trials oleh Revathi Ananthakrishnan, Stephanie Green, Daniel Li, Michael LaValley
Diterbitkan 2018-06-01
Artikel -
5
-
6
-
7
Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma oleh Shinichi Makita, Go Yamamoto, Dai Maruyama, Yuki Asano‐Mori, Daisuke Kaji, Revathi Ananthakrishnan, Ken Ogasawara, Lara Stepan, Claudia Schusterbauer, Nils Rettby, Jens Hasskarl, Koji Izutsu
Diterbitkan 2022-12-01
Artikel -
8
Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study oleh Daniel J. DeAngelo, Wendy Stock, Anthony S. Stein, Andrei Shustov, Michaela Liedtke, Charles A. Schiffer, Erik Vandendries, Katherine Liau, Revathi Ananthakrishnan, Joseph Boni, A. Douglas Laird, Luke Fostvedt, Hagop M. Kantarjian, Anjali S. Advani
Diterbitkan 2017-06-01
Artikel